Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00777088 · ClinicalTrials.gov registry record · NA
Pipeline for Uncoilable or Failed Aneurysms
A NA study, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT00777088 is a NA study that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 108 participants.
The verdict
NCT00777088, a NA study, has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
To determine the safety and effectiveness of Pipeline Embolization Device for the treatment of uncoilable or failed wide-necked intracranial aneurysms (IA).
Interventions
- DEVICE Pipeline Embolization Device (PED)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2008-10 |
| Est. Completion | 2014-09-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00777088
The ClinicalTrials.gov registry entry for NCT00777088 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pipeline Embolization Device (PED) is the first listed.
NCT00777088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00777088 about?
NCT00777088 is a clinical study titled "Pipeline for Uncoilable or Failed Aneurysms". To determine the safety and effectiveness of Pipeline Embolization Device for the treatment of uncoilable or failed wide-necked intracranial aneurysms (IA).
What is the current status of trial NCT00777088?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2008-10. Estimated completion is 2014-09-22.
What interventions are being tested in trial NCT00777088?
The interventions under investigation include: Pipeline Embolization Device (PED) (DEVICE).
Who is sponsoring clinical trial NCT00777088?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.